acemetacin has been researched along with Lupus Erythematosus, Systemic in 1 studies
acemetacin : A carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation. Its activity is due to both acemetacin and its major metabolite, indometacin.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case of a 48-year-old patient with systemic lupus erythematosus is discussed." | 2.39 | [Papular mucinosis. A rare cutaneous manifestation of lupus erythematosus]. ( Kind, P; Meurer, M; Schirren, CG; Storck, R, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Storck, R | 1 |
| Schirren, CG | 1 |
| Meurer, M | 1 |
| Kind, P | 1 |
1 review available for acemetacin and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
[Papular mucinosis. A rare cutaneous manifestation of lupus erythematosus].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Humans; Immunosuppressive Agents | 1994 |